Bronchodilator Response in FEF 25–75 for the Diagnosis of Asthma in Children
Respiratory Care · 2023
DOI: 10.4187/respcare.10177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respiratory Care, 2023. Verfasst von Marcela B Linares und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clínica INDISA, Santiago, Chile. marcelabeatrizl@gmail.com. Hauptthemen laut MEDLINE: Bronchodilator Agents, Asthma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Spirometry tests with a bronchodilator response (BDR) in FEV1, a methacholine concentration that produces a 20% drop in FEV1 (PC20) ≤ 2 mg/mL, and a positive exercise test have high specificity for the diagnosis of asthma in children. However, the value of forced expiratory flow during the middle half of the FVC maneuver (FEF25-75) in spirometry has been questioned. The objective of this study was to relate the BDR in FEF25-75 of spirometry tests with normal FEV1 and FEV1/FVC to airway hyper-responsiveness (AHR) to methacholine or exercise in children age 5-15 y with clinical suspicion of asthma. METHODS: This was a cross-sectional study of spirometry tests performed between January 2017-December 2019 in children age 5-15 y with diagnostic suspicion of asthma who had a methacholine and/or exercise testing within a period not exceeding 60 d between exams. RESULTS: The mean (± SD) age of the children was 9.04 ± 2.67 y, with a range of 5-15 y, and 56.17% were male. Of the 324 spirometry tests with normal FEV1 and FEV1/FVC, 66 (20.4%) tests showed BDR in FEF25-75. A total of 46.9% and 33.3% of the children with and without BDR in FEF25-75, respectively, had a PC20 value ≤ 2 mg/mL and/or a positive exercise testing (P = .039). CONCLUSIONS: Children with suspected asthma and normal spirometry, other than BDR in FEF25-75, had greater AHR than those without BDR in FEF25-75. BDR in FEF25-75 was not always accompanied by AHR to confirm the diagnosis of asthma, so this study suggests that assessment of FEF25-75 alone is not always reliable for ruling in or ruling out AHR in the setting of otherwise normal spirometry results in children with suspected asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clínica INDISA, Santiago, Chile. marcelabeatrizl@gmail.com.
- Pulmonary Function Laboratory, Clínica INDISA, Santiago, Chile.
- Centro de Salud Familiar El Belloto, Servicio de Salud Viña del Mar, Quillota, Valparaíso, Chile.
- Centro de Salud Familiar El Belloto SUR, Servicio de Salud Valparaíso, Valparaíso, Chile; and Hospital Clínico Universidad de Chile, Santiago, Chile.
- Centro de Salud Familiar El Belloto SUR, Servicio de Salud Valparaíso, Valparaíso, Chile; and Universidad Finis Terrae, Santiago, Chile.
- Escuela de Medicina, Universidad Andrés Bello; Research Unit, Clínica INDISA, Santiago, Chile.
Zitieren
APA
Linares, M. B., Rodríguez, M. A., Icarte, D. M., Martínez, B. A., Milla, V. P., Zygier, N. F., & Olmos, C. R. (2023). Bronchodilator Response in FEF 25–75 for the Diagnosis of Asthma in Children. Respiratory Care. https://doi.org/10.4187/respcare.10177
Vancouver
Linares MB, Rodríguez MA, Icarte DM, Martínez BA, Milla VP, Zygier NF, et al. Bronchodilator Response in FEF 25–75 for the Diagnosis of Asthma in Children. Respiratory Care. 2023. doi:10.4187/respcare.10177
BibTeX
@article{Linares2023,
author = {Linares, Marcela B and Rodríguez, María Angelica and Icarte, Danae M and Martínez, Bitter A and Milla, Valentina P and Zygier, Noelia F and Olmos, Claudio R},
title = {Bronchodilator Response in FEF 25–75 for the Diagnosis of Asthma in Children},
journal = {Respiratory Care},
year = {2023},
doi = {10.4187/respcare.10177}
}
EUVIMED